In only five minutes and a penny-sized patch, Mindera Health technology captures thousands of RNA transcripts. We enable scalable collection and analysis of individualized genetic information to provide actionable, data-driven decisions for patients, providers and payers.
MiNDERA Corp has raised $14.0M in total funding. The most recent round was Series A.
MiNDERA Corp is headquartered in San Diego, CA.
In only five minutes and a penny-sized patch, Mindera Health technology captures thousands of RNA transcripts. We enable scalable collection and analysis of individualized genetic information to provide actionable, data-driven decisions for patients, providers and payers.
Choosing the right psoriasis biologic treatment currently involves trial and error.
Mind.Px, a precision medicine test that uses a penny-sized skin patch to capture thousands of RNA transcripts in five minutes, giving providers data-driven treatment decisions.
New York State Department of Health approval (bringing the test to all 50 states), ISO 13485:2016 certification, and a painless patch users compare favorably to a biopsy.
Mindera Health, which makes a psoriasis precision-medicine diagnostic test, closed a $20.3M Series A-3 round led by Mountain Group Partners and Rockmont Investments.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.